MB Gorin - Archives of Ophthalmology, 2007 - Am Med Assoc Molecular genetic studies of age-related maculopathy (ARM), including
family-based linkage studies and case-control association studies, have yielded
valuable insights into the risks of developing this condition and potential ... Cited by 20 - Related articles - BL Direct - All 5 versions
JG Arroyo - JAMA, 2006 - Am Med Assoc Dr G's ophthalmologic history was notable for mild myopia, bilateral drusen, and
an episode of self-limited central serous retinopathy in the left eye at the age
of 38 years. Approximately 3 years ago, he noted subtle vision changes. ... Cited by 13 - Related articles - BL Direct - All 3 versions
R Klein, BEK Klein, MD Knudtson, MF Cotch, … - Archives of Ophthalmology, 2007 - Am Med Assoc Results In analyses controlled for age, sex, race/ethnicity, and study location,
early AMD was associated with a higher serum high-density lipoprotein
cholesterol level (odds ratio per 15 mg/dL, 1.16; 95% confidence interval, ... Cited by 12 - Related articles - BL Direct - All 4 versions
- ►nih.gov R Klein, MD Knudtson, BEK Klein - American journal of ophthalmology, 2007 - Elsevier There were 1,347 and 1,638 persons not using statins and 339 and 429 using
statins at the 1998 to 2000 examination at risk of early and late AMD,
respectively. The unadjusted five-year incidence of early and late AMD, ... Cited by 11 - Related articles - BL Direct - All 14 versions
L Smeeth, I Douglas, AJ Hall, R Hubbard, S … - British Journal of Clinical Pharmacology, 2009 - pt.wkhealth.com RESULTS: People who initiated treatment with a statin (n = 129 288) were
compared with a matched sample of 600 241 people who did not initiate treatment,
with a median follow-up period of 4.4 years. Statin use was not associated ... Cited by 11 - Related articles - All 4 versions
- ►iovs.org HJ Zambarakji, T Nakazawa, E Connolly, AM … - Investigative ophthalmology & visual science, 2006 - ARVO METHODS. Wild-type (C57 Bl/6J) mice received pitavastatin 0.18 mg/kg per day
(group 1), 1.8 mg/kg per day (group 2) or 18 mg/kg per day (group 3) for 3 days
before laser-induced CNV and continued to receive the drug for 14 days. ... Cited by 8 - Related articles - BL Direct - All 3 versions
JY Chuo, M Wiens, M Etminan, DAL Maberley - Ophthalmic Epidemiology, 2007 - informahealthcare.com Purpose : To examine the effect of lipid-lowering agents in the development of
age-related macular degeneration (AMD) through the techniques of meta-analysis.
Methods : Case-control and cohort studies presenting relative risks and 95% ... Cited by 3 - Related articles - BL Direct - All 5 versions
RH Guymer, PN Dimitrov, M Varsamidis, LL … - Clinical Interventions in Aging, 2008 - pubmedcentral.nih.gov Age-related macular degeneration (AMD) is responsible for the majority of visual
impairment in the Western world. The role of cholesterol-lowering medications,
HMG Co-A reductase inhibitors or statins, in reducing the risk of AMD or of ... Cited by 1 - Related articles - All 6 versions
N Kaiserman, S Vinker, I Kaiserman - Current Eye Research, 2009 - informahealthcare.com Purpose: To investigate the effect of statins on the risk for age-related
macular degeneration (AMD) treated with photodynamic therapy (PDT). Methods: All
members in one district of a health maintenance organization in Israel, ... Related articles - All 5 versions
